Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Keros Therapeutics
AddedFeb 19, 2024
UpdatedJun 18, 2026
Keros Therapeutics

Keros Therapeutics

Public

Keros Therapeutics: A global biotech firm innovating treatments for hematological and musculoskeletal disorders.

HQ
Lexington, MA, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Keros Therapeutics is a biotechnology company focused on developing innovative therapies for hematological and musculoskeletal disorders with high unmet medical needs. Their research centers on the transforming growth factor-beta (TGF-ß) family of proteins, aiming to shift treatment paradigms for a wide range of patients. The company's mission is to discover and develop novel treatments that can significantly impact patient care globally.

Keros Therapeutics has made strides in advancing its pipeline, with notable progress in its elritercept (KER-) program. The company has presented clinical data at major medical conferences, demonstrating its commitment to scientific advancement and transparency. Keros continues to evolve its leadership structure to support its growth and research objectives, positioning itself as a key player in the biotechnology sector targeting TGF-ß-related disorders.

Keros Therapeutics - Similar Companies

Kereos logo

Kereos

Kymera Therapeutics logo

Kymera Therapeutics

kymeratx.com

Kestrel Therapeutics logo

Kestrel Therapeutics

Kezar Life Sciences logo

Kezar Life Sciences

Theracos logo

Theracos

theracos.com

Akebia Therapeutics logo

Akebia Therapeutics

akebia.com

Kiniksa Pharmaceuticals logo

Kiniksa Pharmaceuticals

kiniksa.com

NKT Therapeutics logo

NKT Therapeutics

Klogene Therapeutics logo

Klogene Therapeutics

KSQ Therapeutics logo

KSQ Therapeutics

ksqtx.com

KinDex Pharmaceuticals logo

KinDex Pharmaceuticals

Kinaset Therapeutics logo

Kinaset Therapeutics

kinasettx.com

Kriya Therapeutics logo

Kriya Therapeutics

Lumos Pharma logo

Lumos Pharma

lumos-pharma.com

K36 Therapeutics logo

K36 Therapeutics

k36tx.com

Keros Therapeutics - Quick Facts

Who are Keros Therapeutics' competitors?

Companies similar to Keros Therapeutics include Kereos, Kymera Therapeutics, Kestrel Therapeutics and Kezar Life Sciences.

When was Keros Therapeutics founded?

Keros Therapeutics was founded in 2015.

Where is Keros Therapeutics' headquarters located?

Keros Therapeutics' headquarters is located in Lexington, MA, US.

When was Keros Therapeutics' last funding round?

Keros Therapeutics' most recent funding round was for $140M (USD) in January 2024.

How much has Keros Therapeutics raised to-date?

As of Jan 3, 2024, Keros Therapeutics has raised a total of $230M (USD).

How many employees does Keros Therapeutics have?

Keros Therapeutics has 105 employees as of Feb 6, 2024.

Keros Therapeutics - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Biopharmaceuticals
Tags
  • Therapeutics
Unique IDs
  • ein: 811173868
  • secCik: 0001664710
  • ticker: KROS
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research